Titan Medical to Present at the Society of Robotic Surgery 2020 World Robotic Symposium
July 27 2020 - 7:00AM
Business Wire
Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD)
(Nasdaq: TMDI), a medical device company focused on the design
and development of single-port robotic surgical technologies,
announces that David McNally, President and CEO of Titan Medical,
will present in the plenary session titled “Future Robotic
Platforms” on Saturday, August 1 at the Society of Robotic Surgery
(SRS) 2020 World Robotic Symposium. This industry-focused plenary
session will feature executives from companies recognized for
current and promising technology platforms in robotic surgery.
Mr. McNally, said, “We are honored to present a progress update
on our single-port robotic surgery system at the Society of Robotic
Surgery 2020 World Robotic Symposium, where we will be among
clinical and industry experts in the field of robotic surgery. We
are pleased to continue our support for the SRS, which through this
year’s virtual World Robotic Symposium, provides an exceptional
venue for Titan to present and be recognized among robotic surgery
innovators.”
The Society of Robotic Surgery 2020 World Robotic Symposium is a
virtual meeting designed to be the most comprehensive robotic
surgery symposium, featuring internationally renowned faculty who
are dedicated experts in their fields of study.
About Titan Medical Inc.
Titan Medical Inc. is focused on robotic-assisted technologies
for application in minimally invasive surgery (“MIS”). Titan is
developing a single-port robotic surgical system comprised of a
surgeon-controlled patient cart that includes a dual-view camera
system with 3D and 2D high-definition vision systems and
multi-articulating instruments for performing MIS procedures, and a
surgeon workstation that provides an ergonomic interface to the
patient cart and a 3D high-definition endoscopic view of the MIS
procedure. Titan intends to initially pursue gynecologic surgical
indications for use of its single-port robotic surgical system.
For more information, please visit the Company’s website at
www.titanmedicalinc.com.
Forward-Looking Statements
This news release and the referenced presentation contain
“forward-looking statements” within the meaning of applicable
Canadian and U.S. securities laws. Such statements reflect the
current expectations of management of the Company’s future growth,
results of operations, performance and business prospects and
opportunities. Wherever possible, words such as “may”, “would”,
“could”, “will”, “anticipate”, “believe”, “plan”, “expect”,
“intend”, “estimate”, “potential for” and similar expressions have
been used to identify these forward-looking statements. These
statements reflect management’s current beliefs with respect to
future events and are based on information currently available to
management. Forward-looking statements involve significant risks,
uncertainties and assumptions. Many factors could cause the
Company’s actual results, performance or achievements to be
materially different from any future results, performance or
achievements that may be expressed or implied by such
forward-looking statements, including, without limitation, those
listed in the “Risk Factors” section of the Company’s Annual Report
on Form 20F dated March 30, 2020 (which may be viewed at
www.sedar.com and at www.sec.gov). Should one or more of these
risks or uncertainties materialize, or should assumptions
underlying the forward-looking statements prove incorrect, actual
results, performance, or achievements may vary materially from
those expressed or implied by the forward-looking statements
contained in this news release. These factors should be considered
carefully, and prospective investors should not place undue
reliance on the forward-looking statements. Although the
forward-looking statements contained in the news release are based
upon what management currently believes to be reasonable
assumptions, the Company cannot assure prospective investors that
actual results, performance or achievements will be consistent with
these forward-looking statements. Except as required by law, the
Company expressly disclaims any intention or obligation to update
or revise any forward-looking statements whether as a result of new
information, future events or otherwise.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200727005151/en/
Stephen Randall Chief Financial Officer +1-416-548-7522
stephen@titanmedicalinc.com
Titan Medical (NASDAQ:TMDI)
Historical Stock Chart
From Apr 2024 to May 2024
Titan Medical (NASDAQ:TMDI)
Historical Stock Chart
From May 2023 to May 2024